Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 23,72€ (+8,11%). La mediana es de 21,88€ (−0,27%).
| Comprar |
9 |
| Mantener |
12 |
| Vender |
2 |
Noticias Ir al feed de noticias
Doximity CEO sells 8,505 shares to cover tax withholding after equity vesting
Doximity CEO Jeffrey Tangney sold 8,505 Class A shares on August 15 to satisfy tax withholding from vested awards, a non-discretionary transaction that reduced his direct stake by roughly 0.3% to 2,531,955 shares (about 1% ownership). The sale does not reflect a market judgment by Tangney and three other insiders had similar withholdings the same day. Company results show slowing top-line growth, margin pressure from rising AI compute costs, and a guidance lull as AI-related revenue recognition is expected later in the year, while the stock has fallen over 60% in the past year. » Más en finance.yahoo.com
Doximity granted president 150,000 options as he sold small stake to cover taxes
Doximity president Steven L. Zatz sold 4,482 Class A shares in a non‑discretionary sell‑to‑cover to satisfy tax withholding after RSU vesting and retains 51,864 shares (~$1.29m at $24.80). The company granted Zatz 150,000 options on July 22 with a $20.49 strike that begin vesting in July 2027, tying future pay to stock appreciation. Doximity reported Q2 revenue of $156.6m (7% growth) and raised its full‑year range while AI compute costs lowered gross margin to 87.5% and adjusted EBITDA fell 6% to $74.8m; management says higher‑than‑expected AI usage should drive future revenue recognition. Investors should note the option grant links executive upside to stock performance as AI‑related costs and upcoming AI revenue recognition will affect margins and earnings. » Más en finance.yahoo.com
Doximity CFO sells shares to cover taxes but keeps $12.1 million stake
Doximity CFO Matthew Sonefeldt reported a non-discretionary sale of 15,311 Class A shares on August 15 to satisfy tax obligations from equity vesting, leaving him with 486,238 shares valued at about $12.1 million. The filing does not signal a change in his view of the company. Doximity posted TTM revenue of $655.6 million and net income of $167.0 million, but guided to roughly 1% revenue growth for the September quarter as AI-related timing and higher AI compute costs pressured gross margin and adjusted EBITDA; the company also spent $91.6 million on share repurchases. Investors should note the transaction was routine vesting-related withholding and weigh it against the company's mixed near-term growth outlook and solid profitability. » Más en finance.yahoo.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | jun 2026 | |
|---|---|---|
| Ingresos | 137,23M | 10,85% |
| Beneficio bruto | 116,47M | 5,50% |
| Beneficio neto | 21,31M | 52,90% |
| EBITDA | 39,12M | 31,11% |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 3,97B€ |
Número de acciones | 187,03M |
Máximo/mínimo de 52 semanas | 65,65€ - 14,72€ |
| Dividendos | No |
Beta | 1,21 |
Ratio P/E | 27,80 |
Ratio PEG | −0,97 |
Ratio P/B | 4,93 |
Ratio P/S | 7,06 |
Perfil de la empresa
Doximity, Inc. betreibt eine Cloud-basierte digitale Plattform für medizinische Fachkräfte in den Vereinigten Staaten. Die Plattform des Unternehmens bietet seinen Mitgliedern Tools, die speziell für Mediziner entwickelt wurden und es ihnen ermöglichen, mit ihren Kollegen zusammenzuarbeiten, die Patientenversorgung zu koordinieren, virtuelle Patientenbesuche durchzuführen, sich über die neuesten medizinischen Nachrichten und Forschungsergebnisse auf dem Laufenden zu halten und ihre Karriere zu verwalten. Das Unternehmen bedient in erster Linie Pharmahersteller und Gesundheitssysteme. Das Unternehmen war früher als 3MD Communications, Inc. bekannt und änderte im Juni 2010 seinen Namen in Doximity, Inc. Doximity, Inc. wurde im Jahr 2010 gegründet und hat seinen Hauptsitz in San Francisco, Kalifornien.
| Nombre | DOXIMITY INC DL-,001 |
| CEO | Jeffrey A. Tangney |
| Sede | San Francisco,
ca Estados Unidos |
| Sitio web | |
| Sector | Salud |
| Industria | Tecnología sanitaria |
| Salida a bolsa | 02/01/2008 |
| Empleados | 880 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NYSE | DOCS |
Descubrir activos
Los accionistas de DOXIMITY INC DL-,001 también invierten en los siguientes activos
